Compare AEIS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEIS | ASND |
|---|---|---|
| Founded | 1981 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 13.6B |
| IPO Year | 1996 | 2014 |
| Metric | AEIS | ASND |
|---|---|---|
| Price | $308.87 | $230.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 16 |
| Target Price | $278.36 | ★ $279.50 |
| AVG Volume (30 Days) | 512.1K | ★ 642.0K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.13% | N/A |
| EPS Growth | ★ 168.53 | N/A |
| EPS | ★ 3.84 | N/A |
| Revenue | ★ $453,095,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.24 | $43.13 |
| P/E Ratio | $80.32 | ★ N/A |
| Revenue Growth | ★ 38.39 | N/A |
| 52 Week Low | $75.01 | $124.06 |
| 52 Week High | $350.00 | $248.60 |
| Indicator | AEIS | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 52.12 | 50.50 |
| Support Level | $288.91 | $190.49 |
| Resistance Level | $350.00 | $245.30 |
| Average True Range (ATR) | 15.56 | 9.13 |
| MACD | -4.94 | -1.46 |
| Stochastic Oscillator | 32.93 | 38.67 |
Advanced Energy Industries Inc provides precision power conversion, measurement, and control solutions. The company designs, manufactures, sells, and services power electronics conversion products that transform raw electrical power into controllable, usable power for complex equipment. It operates in one reporting segment, Power Electronics Conversion Products, serving the Semiconductor Equipment, Data Center Computing, Industrial and Medical, and Telecom and Networking markets. Its products include Plasma Power Products, AC-DC Power Supply Units, DC-DC Converters, High Voltage solutions, SCR Power Controllers, and Sense and Measurement solutions. The company operates in the United States, Asia, Europe, and other regions.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.